A comprehensive analysis of the OECD's warning regarding the systemic risks posed...
Technicals for Ajanta Pharma Limited
By MusingTheNews
2025-07-16 20:22
Overall Technical outlook
Price Summary
On 2025-07-15, Ajanta Pharma Limited's shares started at 2662.0, peaked at 2715.4, bottomed out at 2627.9, and ended 1.34% higher at 2697.7, with 391905 shares traded. The peak price for the stock in the past 52 weeks is 3426.5, with the lowest price being 2285.1. 12 analysts suggest that AJANTPHARM's future price will lie between 2288.0 and 3293.0, with an average expected price of roughly 2980.0.
Technicals
Support and Resistance: At 2697.7, the price is held up by support at 2568.65 and faces resistance at 2788.4 for AJANTPHARM. This suggests a trading range where 2568.65 provides a base and 2788.4 limits upward movement. Support/Resistance for AJANTPHARM
Aroon: The AROON is in a neutral stance, with no clear direction indicated for the market. This lack of clarity suggests that the market may be in a state of equilibrium for AJANTPHARM, with no strong trend emerging. Aroon chart for Ajanta Pharma Limited
Bol. Bands: The BOLL BANDS is showing a neutral stance, with no definitive indication of an upward or downward trend for AJANTPHARM. This neutral position suggests a period of indecision in the market, making it difficult to predict the next move. Bolinger Bands chart for Ajanta Pharma Limited
Parabolic SAR: The PSAR for AJANTPHARM maintains a bullish outlook, establishing a crucial support level that may help maintain the current upward momentum. This strong support suggests that the market is poised to continue its upward trend, providing confidence in the ongoing bullish sentiment. Parabolic Stop and Reverse chart for Ajanta Pharma Limited
Stochastic: The STOCHASTIC is in a neutral stance, with no clear signals for movement up or down. This neutral position indicates a potential period of consolidation or uncertainty in the market. Stochastic chart for Ajanta Pharma Limited
Tripple Moving Agerage: The current state of the Tripple MOVING AVG is neutral for AJANTPHARM, providing no clear indication of a trend in either direction. This suggests that the market may be lacking momentum, making it difficult to predict future movements. Tripple SMA chart for Ajanta Pharma Limited
A comprehensive approach to analyzing a company requires considering both its technical and fundamental aspects. The company's fundamentals, such as its earnings, growth prospects, and financial health, provide a strong foundation for understanding technical indicators. Additionally, examining the industry it operates in helps contextualize the company's position within the broader market. By integrating these factors, one can gain more valuable insights into the company's stock performance and potential investment opportunities.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
An in-depth examination of the factors contributing to the U.S. dollar's multi-year...
By clicking "Accept", you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our tailored marketing efforts.